Please use this identifier to cite or link to this item: http://repositorio.ufla.br/jspui/handle/1/48859
Title: Regulation of protein synthesis: an approach to treat Autistic Spectrum Disorder (ASD)
Keywords: Neurodevelopment
Translation
mTOR
eIF4E-eIF4G
mGluR
GRK5
Mammalian target of rapamycin (mTOR)
Issue Date: 19-Apr-2021
Publisher: Bentham Science Publishers
Citation: TEIXEIRA, J. P.; RAMALHO, T. C. Regulation of protein synthesis: an approach to treat Autistic Spectrum Disorder (ASD). Current Medicinal Chemistry, [S.l.], v. 28, n. 34, p. 7141-7156, Apr. 2021. DOI: 10.2174/0929867328666210419125634.
Abstract: Autism Spectrum Disorder (ASD) is a disorder with different etiologies and poor elucidation, characterized by changes in social and cognitive skills. ASD impacts a large number of people in the world. Surprisingly, in spite of its great importance, just modest progress has been achieved towards comprehending this pathology and designing new therapies. The molecular dysfunctions observed in people with autism are evidenced by the interference in the synthesis of synaptic proteins, which impairs their development and plasticity, leading to characteristics of individuals with ASD. The present work investigates the mTOR pathway and the proteins related to its regulation and neurological functioning. The path of protein synthesis and translation is promising to treat various disorders and its elucidation may, for example, result in drugs that facilitate the diagnosis and broaden the range of treatments, improving the quality of life of ASD patients.
URI: https://www.eurekaselect.com/article/115384
http://repositorio.ufla.br/jspui/handle/1/48859
Appears in Collections:DQI - Artigos publicados em periódicos

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.